Des renomierten Augenspiegels wird über das im Rahmen des siebten Förderprogramms der Europäischen Gemeinschaft (FP7) bewilligte Forschungsprojekt VISICORT berichtet

In der Oktoberausgabe des renomierten Augenspiegels wird über das im Rahmen des siebten Förderprogramms der Europäischen Gemeinschaft (FP7) bewilligte Forschungsprojekt VISICORT berichtet. Die immun-vermittelte Abstossung von allogenen (nicht-verwandten) Organen ist nach wie vor ein grosses Problem in der Transplantationsmedizin, welches auch durch die Verabreichung von immunsuppressiven Medikamenten nicht nachhaltig verhindert werden kann. Read more

Stem cell research to fight cornea transplant rejection featured on RTÉ

rte

New research from NUI Galway is using adult stem cells in the fight against cornea transplant rejection. The research has been published in the American Journal of Transplantation, and underpins a pan-European project which hopes to help the 100,000 people worldwide who undergo cornea transplant procedures each year.

Read more

VISICORT lends support to ReelLife Science, a new science video project for students

VISICORT will be taking part in ReelLife Science,  an exciting new science video competition for primary and secondary schools. The competition is the first of its kind in Ireland, and VISICORT will be sharing its expertise on the theme of “Vision”.

Read more

VISICORT abstract accepted for oral presentation at ESBB’s 2014 Annual Conference, Leipzig

VISICORT have had an abstract accepted for oral presentation at ESBB’s 2014 Annual Conference. The ESBB conference will take place in Leipzig, Germany from Tuesday 21st to Friday 24th October.

Read more

VISICORT featured in NUI Galway magazine “Research Matters”

VISICORT recently featured in the NUI Galway Magazine ‘Research Matters’ in an article titled ‘VISICORT – NUI Galway to Lead New 6 Million EU Project Tackling Corneal Transplanatation Failure.’

Read more

Launch of VISICORT

Welcome to the VISICORT Project.  We are very excited to be launching the project in April 2014.

Please follow us on facebook or twitter for more updates.